| Full Name | April Johnson |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 9520 Amethyst Dr, Daphne, Alabama |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225529738 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 4519 (Alabama) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| April Johnson, 30941 Mill Ln Ste G, #320, Spanish Fort, AL 36527 Ph: (251) 202-2268 | April Johnson, 9520 Amethyst Dr, Daphne, AL 36526 Ph: (251) 202-2268 |
News Archive
Allon Therapeutics Inc. announced today the completion of its first phase of work in a preclinical Parkinson's disease model and advancement into the second phase of work. Both phases are funded by The Michael J. Fox Foundation for Parkinson's Research and carried out by Prof. Marie-Francoise Chesselet's lab at the University of California Los Angeles.
According to researchers, screening for the AIDS virus to include every American at least once and the highest-risk people once a year could prevent more than 80,000 infections over the next 20 years. The team from Yale University in Connecticut and Stanford University in California reported that if treatment for infected people were integrated into such a program, it would prevent an estimated 212,000 new infections.
Multiple myeloma is one of the most common blood cancers, and at present considered to be incurable. In a new study from Uppsala University, researchers now present a conceptually new model for the development and progression of multiple myeloma. The study was done in collaboration with Vrije Universitet Brussels and is published in the July edition of the on-line journal PLoS ONE.
Evotec AG today announced the signing of a definitive agreement to acquire all shares in Kinaxo Biotechnologies GmbH, a Munich-based drug discovery alliance company supporting the development of targeted drugs.
GSK Consumer Healthcare today announced it will update the alli product label to alert consumers to certain symptoms that have been associated with rare instances of severe liver injury reported in people taking orlistat, the active ingredient in alli. This update follows FDA's completion of its safety review of orlistat and is being implemented in conjunction with Roche, the manufacturer of the prescription dose of orlistat (Xenical). The agency stated that a cause and effect relationship has not been established.
› Verified 2 days ago
Rachel Arzaga, M.S., CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 26420 Kensington Pl Ste C, Daphne, AL 36526 Phone: 251-517-0355 | |
Ms. Breanne Dutter Kirchler, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 101 Villa Dr, Daphne, AL 36526 Phone: 251-621-4200 | |
Whitney Smith, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 11626 Us Highway 90, Daphne, AL 36526 Phone: 601-573-9712 | |
Renee Stutes Howard, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8909 Rand Ave, Daphne, AL 36526 Phone: 251-210-1632 | |
Ms. Shelley Tyrrell Scott, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 11125 Pontchartrain Loop, Daphne, AL 36526 Phone: 251-626-2366 | |
Jubilee Speech Therapy Llc Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 12482 Cressida Loop, Daphne, AL 36526 Phone: 985-707-5599 | |
Mrs. Melanie Brady Waters, M.C.D., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 29000 Highway 98 Ste 202b, Daphne, AL 36526 Phone: 251-786-8255 |